Objectives Macrophages are central to the inflammatory processes driving rheumatoid arthritis (RA) synovitis. The molecular pathways that are induced in synovial macrophages and thereby promote RA disease pathology remain poorly understood.
Introduction
Rheumatoid arthritis (RA) is a debilitating autoimmune inflammatory condition of unknown etiology. RA affects approximately 1% of the population and is associated with increased morbidity, reduced life expectancy, a heightened degree of social burden and economic cost. The primary site of inflammation is the synovium, characterised by hyperplasia and vascularisation, inflammatory cell infiltration, hypoxia and destruction of adjacent cartilage and bone. This ultimately leads to irreversible destruction of the joint and impaired mobility. Although the use of biologic therapeutics has considerably improved clinical outcomes and prognosis, they remain effective in only a proportion of patients and rates of long-term remission achieved remain low. There is therefore an ever-greater need to understand the cellular and molecular processes by which pathology is mediated to develop future therapeutics.
Macrophages constitute the major leukocyte population within the synovial inflammatory infiltrate (≥40%). [1] Synovial macrophage numbers directly correlate with measures of disease activity and severity including; CRP, ESR, swollen joint count, synovial lining layer vascularity and thickness, the presence of citrillinated peptides and radiologic score. [2, 3] Furthermore, the number of synovial lining layer CD68 + macrophages provide a useful biomarker of response upon successful clinical intervention in the context of clinical trials. [4] [5] [6] [7] As macrophages are a major source of IL-6 and TNFα, the recent success of anticytokine therapeutics supports the notion that macrophage targeted therapies may be beneficial for the treatment of RA (reviewed in, [8] ) and highlight a central role for macrophages in the progression of human disease pathology.
There are multiple mechanisms by which synovial macrophages may contribute towards the inflammatory burden and joint destruction in RA. [9] Proinflammatory cytokines and immune complexes present in plasma induce early activation of CD14 + monocytes, up-regulation of integrins and chemokine receptors (e.g. CCR1 and CCR2) and trans-endothelial migration of monocytes into the synovium. Monocytes accumulate in the synovium where high concentrations of M-CSF and GM-CSF enhance monocyte to macrophage differentiation and maturation.
The advent of transcriptional array techniques allows definitive characterisation of the pathways that are active within a given cell population. We therefore adopted a microarray-based approach to elucidate the molecular pathways that are activated in RA Synovial Fluid (SF) macrophages to identify novel pathways that could drive disease pathology. Using this approach we now report the unexpected prominence of the cholesterol activated Liver X Receptor (LXR) pathway that integrates with TLR pathways to enhance synovial cytokine secretion.
Methods

Reagents
GW3965 (Merck UK) was dissolved in DMSO.
Tissues and patient samples
Blood, SF and synovial membrane samples were obtained from patients with RA after obtaining their written informed consent. Patient numbers and characteristics are shown in Supplementary Table 1 . This study complied with the World Medical Association Declaration of Helsinki and was approved by the Glasgow East Ethics Committee. All samples were processed immediately upon arrival by centrifugation on a histopaque density gradient to separate out the peripheral blood mononuclear cells followed by MACS CD14 positive selection. [10] The samples were lysed in Trizol and stored at -70 o C prior to RNA extraction. Cell purities were typically >95% (data not shown).
RNA purification and analysis
Single cell suspensions were lysed in buffer RLT or Trizol and the RNA extracted following the RNeasy micro kit (Qiagen). Gene expression was analysed using SYBR green QRT-PCR master mix on an ABI7900HT and SDS 2.3 software (Applied Biosystems). Gene expression was normalised to TATA binding protein (TBP) or GAPDH. Primer Sequences are shown in Supplementary Table 2 .
Microarray analysis
The integrity of RNA was ensured by analysis of ribosomal 18S and 28S RNA intensity using an Agilent 2100 Bioanalyser (Agilent Technologies). Following genomic DNA digestion cDNA was synthesised, fragmented and biotin labelled (FL-Ovation™ cDNA Biotin Module V2 kit -Nugen Technologies). An Affymetrix GeneChip® Human Genome U133 Plus 2.0 Array was performed using a GeneChip® Scanner 3000. Background correction and normalisation for each probe set on the GeneChips was determined by the RMA algorithm using R and
Bioconductor and quality assured using arrayQualityMetrics. [11] Further analysis and differential gene expression studies were carried out using oneChannelGUI.
A pfp (predictor of false positive) value of 0.05 was chosen to determine differentially expressed genes. Pathway analysis was performed using Ingenuity
Pathway Analysis (IPA -Ingenuity Systems). The microarray data produced in this study is MIAME compliant (http://www.mged.org/Workgroups/MIAME/miame.html) and will be submitted to the ArrayExpress database (www.ebi.ac.uk/arrayexpress) once the manuscript is accepted for publication.
Cell culture
Cells were cultured at a density of 1.0 x10 5 / well in a 96 well plate (Corning) and matured to a macrophage phenotype as previously described. [10, 12] Cells were pre-incubated with GW3965 or vehicle at the indicated concentration for 48 hours prior to addition of TLR ligands; 100 ng/ml ultra pure lipoplysacchardide (LPSCalbiochem), 10 µg/ml Lipoteichoic acid (LTA), 10 µg/ml Pam 3 CSK4 or 1 µg/ml CL097 (Autogen) for 24 hours.
Cytokine analysis
The concentration of cytokines in cell culture supernatants was analysed by ELISA or luminex as previously described. [10] Immunofluorescence 5 µM sections were deparaffinised, rehydrated and epitope retrieval was performed using citrate buffer followed by incubation with 20% horse serum.
Primary antibodies were incubated overnight at 4 o C in 5% serum/ TBST at final concentration of 2.5 µg/ml LXRα (Abcam -clone PPZ0412), 2.6 µg/ml LXRβ (Santa Cruz -polyclonal), 2.5 µg/ml CD68 (Dako -clone PG-M1) or isotype controls (Dako). Biotinylated secondary antibodies were incubated for 30 min in 5% serum/TBST followed by incubation with Avidin-D fluorochrome conjugates (Vectorlabs; LXRα/β -Fluorescein or CD68 -Texas Red) for 45 min in PBS.
Slides were mounted in vectashield containing DAPI (Vectorlabs) and visualised under a fluorescent microscope (Axiovert S100 and Openlab software).
Statistical analysis
Results are displayed as mean ± standard deviation. Statistical analysis was by paired Students t test, Wilcoxon paired t test or Two-Way Anova using the Graph Pad Prism 4 software. The significance of association between the differentially expressed genes and canonical pathways within IPA was determined using
Fisher's exact test and corrected using Benjamini-Hochberg correction for multiple testing.
Results
Analysis of the synovial fluid derived macrophage transcriptome
To determine the gene expression profile that defines an RA SF macrophage, microarray analysis was performed on sorted SF macrophages and the transcriptome compared to that of matched peripheral blood monocytes 
The LXR pathway is highly up-regulated in RA synovial fluid macrophages
We next examined the canonical biological pathways most associated with this transcriptional profile using IPA. The pathway most significantly induced in SF macrophages was the LXR/RXR nuclear receptor activated pathway (Supplementary Table 3 and Supplementary Table 4) .
Confirmation of LXR activation and induction of downstream gene expression
To 
LXR protein is present in synovial macrophages
We next sought to demonstrate the presence of LXRα and LXRβ protein particularly within synovial macrophages. Sections derived from RA synovial membrane biopsies were stained with antibodies against either LXRα or LXRβ in combination with CD68. We detected LXRα (40%) and LXRβ (36%) positive macrophages in RA synovial membranes ( Figure 4A-C) .
Macrophage differentiation up-regulates LXRα expression
Migration into the synovium induces the differentiation of monocytes into macrophages. [13, 14] We therefore examined the level of LXRα expression during the differentiation of healthy peripheral blood monocytes to a macrophage phenotype. In all four donors tested, LXRα was significantly increased between 10 and 150 fold over 6 days ( Figure 5A ). In contrast, LXRβ was significantly down-regulated by approximately two fold ( Figure 5B ) whereas the basal level of ABCA1 expression, as a reporter of LXR activation, was not significantly different between monocytes and macrophages, but could be increased by addition of the LXR agonist GW3965 ( Figure 5C ). Together these results suggest that whereas macrophage differentiation can alter the relative level of LXRα and LXRβ expression it is not sufficient alone to induce activation of the LXR pathway.
Studies have previously shown that administration of GW3965 to LPSactivated monocytes or macrophages potentiates the secretion of proinflammatory cytokines. [10, 15] To determine if the difference in the level of LXR expression between monocytes and macrophages impacts the level of subsequent cytokine secretion we treated syngeneic monocytes and macrophages for 48 hours with GW3965 followed by stimulation with 100 ng/ml LPS. After 24 hours the concentration of TNFα in cell culture supernatants was measured by ELISA. In agreement with previous observations LXR agonism significantly increased the secretion of TNFα from LPS stimulated monocytes ( Figure 5D and, [10] ). In comparison to monocytes at the same concentration of GW3965, macrophages secreted significantly higher levels of TNFα in response to stimulation with LPS suggesting that the higher level of LXR expression in macrophages enhances inflammatory cytokine secretion.
TNFα augments the expression of LXRα in human macrophages
Differentiation of monocytes to macrophages enhances the level of LXR 
LXR activation potentiates TLR driven cytokine secretion in human macrophages
Our microarray analysis also showed that the expression of genes known to be involved in the inhibition of Retinoid X Receptor (RXR) function were highly significantly up-regulated in SF macrophages (Supplementary Figure 5D and, [10, 15] ). However, the effect of LXR agonism upon cytokine secretion induced by ligation of TLR2, TLR7 and TLR8 is unknown.
Human M-CSF matured macrophages were cultured in the presence of GW3965
for 48 hours prior to stimulation with TLR ligands; LPS (TLR4) and CLO97
(TLR7/8). TLR2 (TLR1/2 or TLR2/6) can be stimulated with either PAM 3 CSK4 or LTA; however, these ligands exert differential effects in macrophages and therefore both of these TLR2 ligands were used in parallel. [22] In accordance with our previous findings, LXR agonism by addition of GW3965 significantly increased the secretion of TNFα from LPS stimulated human macrophages in a dose dependent manner ( Figure 6A ). Furthermore, LXR agonism augmented the secretion of TNFα from macrophages stimulated with ligands for TLR2 ( Figure   6B and C) or TLR7/8 ( Figure 6D ). Luminex analysis of cell culture supernatants showed that this was not specific to TNFα as the secretion of other proinflammatory cytokines, IL-1β, IL-6, IL-12 and G-CSF, and inflammatory chemokines, MIP-1α (CCL3) and MIP-1β (CCL4), that are typically secreted upon TLR ligation were also increased from macrophages stimulated with LPS ( Figure   6E ), LTA ( Figure 6F ) PAM 3 CSK4 ( Figure 6G ) and CL097 ( Figure 6H ). There was a significant increase in IL-1RA but no significant difference in the concentration of IL-10 ( Figure 6F , G and H and data not shown).
Discussion
By adopting a hypothesis free approach we have utilised microarray technology to elucidate the molecular pathways that are induced within RA SF macrophages. Importantly, we have shown that the transcriptome of SF macrophages differs considerably compared to peripheral blood monocytes.
Furthermore, we have shown that the LXR pathway is highly induced and is a novel potential driver of RA disease pathology that is in part mediated by augmentation of TLR induced cytokine secretion.
Our studies show that the expression of LXRα is increased during 
